We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture.
Biostrategy, Biomeasurement and Biomanufacture
Getting to market as the world transforms
Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change.
Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret of business success in Bioinnovation.
Gaining insight with better information
Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimisation. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software.
Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyse productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical devices.
Scaling up and delivering at viable cost
Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimisation and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance.
We can help you optimise processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimisation and equipment design to enable the successful manufacture and delivery of your product or advanced medicinal therapy.
Talk to us about world-changing science
Proven in biodesign
Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture.
Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.
Meet the core team
Tech, tools & facilities
Synthetic biology labs
Located in our Cambridge head office, our microbiology lab enables us to genetically modify micro-organisms and characterise them. Our facilities are containment level 2 rated for handling pathogenic strains and our in-house libraries allow rapid modular DNA construct design and assembly. We are particularly interested in building organisms that are biological sensors for healthcare and industrial biotech applications.
Life science labs
Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.
Cell culture labs
Our life science and synthetic biology facilities are complemented by our recently established cell culture labs. They support our clients in the advanced therapies and medicinal products field to deliver the most advanced drugs on the planet. We’ve equipped them with tools to monitor, grow and store cells which are relevant to cell and gene therapy process development.
Enabling the world's first DNA-based platform for massive data storage
Harnessing the science of synthetic biology and best-in-class automation to turn organic waste into high-protein fish food.
Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks
News & insights
This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery.
- AI & Analytics
- Digital health
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the successful close of its Series B funding.
Cambridge Consultants wins two prestigious iF DESIGN AWARDS for Aalto, an injection device for rheumatoid arthritis patients, and Alma a smart cooling case for injectable fertility drugs.
Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...
- Innovation management
- Product realisation
- Strategic advice
GapSummit is the premier, global, intergenerational biotechnology summit. Industry world leaders, and the next generation of leaders, gather to substantively discuss pressing challenges facing the bioeconomy and catalyse innovation to address them. Join us on September 28 as we discuss the challenges in R&D and explore new models of innovation to bridge this industry-wide Gap.
The Beauty Summit Global Summit will delve into the next generation technology in consumer health and beauty. If you are attending the show visit Cambridge Consultants booth to take a look at the latest developments in personalization and speak to global industry leaders
We are bringing together innovators and market leaders in technology and beauty to discuss the challenges behind personalization in the beauty sector.
At SynBioBeta Digital see how synthetic biology is disrupting consumer products, food, agriculture, medicine, chemicals, materials, and more. The SynBioBeta Global Synthetic Biology Conference 2020 unites the leading biological engineers, investors, innovators, and entrepreneurs who make up this fast-growing industry.